Investor
BioPharma America
A focused life sciences partnering conference facilitating dealmaking, licensing, and investment discussions between biotech companies and global pharmaceutical partners.
- When
- September, Late September
- Where
- Boston, United StatesView on Google Maps
- Format
- In person
- Organiser
- EBD Group
- Region
- North America
- Scale
- About 800 attendees
- Founded
- 2008
The Signal
BioPharma America is a high level partnering conference focused on early stage life science dealmaking. Held in Boston, the meeting utilizes specialized software to organize direct, face to face negotiations between biotech startups and pharmaceutical business development teams. The agenda covers licensing, venture capital trends, and computational biology platforms. For technology providers, this event offers a direct route to present computational drug discovery platforms to active buyers.
What to expect
- Early stage licensing and research deals
- Pharmaceutical venture capital trends
- Academic tech transfer announcements
Who is in the room
Biotechnology founders, pharmaceutical licensing directors, life science venture capitalists, and academic tech transfer officers attend.
Background
Established in Boston to leverage the dense regional life sciences ecosystem, the event has maintained a sharp focus on business development. It has adapted over time to include a growing number of computational biology and digital platform developers.
Related events
Running this event, or spotted something out of date?